|
Patients studied – site of infection |
|||
| Site of infection |
Total no. of patients in this category |
Number of patients suitable for switch to oral therapy (% of patients with this site of infection) |
Number of patients suitable for switch to oral therapy and early discharge (% of patients with this site of infection) |
|
|
|||
| Blood |
40 |
8 (20%) |
3 (8%) |
| Sputum |
40 |
2 (5%) |
2 (5%) |
| Skin/Soft tissue |
118 |
77 (65%) |
54 (46%) |
| Other |
13 |
6 (46%) |
3 (23%) |
|
|
|||
| Total |
211 |
93 |
62 |
Desai et al. BMC Infectious Diseases 2006 6:94 doi:10.1186/1471-2334-6-94 |
|||